Michael Rosenblatt - 19 May 2022 Form 3 Insider Report for Axcella Health Inc.

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 19 May 2022
Net transaction value: $0
SEC form: 3
Accepted by SEC: 23 May 2022, 16:53:07 UTC
Prior SEC filing: 13 May 2022
Next SEC filing: 15 Feb 2023
Source filing: View source filing
Reporting owner signature: /s/ Paul Fehlner, Attorney-in-Fact

Key filing fact

Michael Rosenblatt filed Form 3 for Axcella Health Inc. on 23 May 2022.

Key facts

This page summarizes Michael Rosenblatt's Form 3 filing for Axcella Health Inc..
0 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 23 May 2022, 16:53.

Change

Previous filing in this sequence was filed on 13 May 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AXLA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 3,053
Date: 19 May 2022
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AXLA holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 19 May 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,732
Exercise price: $6.52
Footnotes: F1

AXLA holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 19 May 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 4,071
Exercise price: $6.21
Footnotes: F1

AXLA holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 19 May 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 5,428
Exercise price: $13.83
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

This option is fully vested and exercisable as of the date hereof.

Footnote F2

4,408 shares underlying this option are fully vested and exercisable, with the remainder vesting in substantially equal installments on each of June 30, 2022, September 30, 2022 and December 31, 2022.

SEC remarks

Exhibit 24 - Power of Attorney